WO2021082294A1 - Preparation of and method for immunomodulatory peptide - Google Patents

Preparation of and method for immunomodulatory peptide Download PDF

Info

Publication number
WO2021082294A1
WO2021082294A1 PCT/CN2020/073062 CN2020073062W WO2021082294A1 WO 2021082294 A1 WO2021082294 A1 WO 2021082294A1 CN 2020073062 W CN2020073062 W CN 2020073062W WO 2021082294 A1 WO2021082294 A1 WO 2021082294A1
Authority
WO
WIPO (PCT)
Prior art keywords
pro
protein
immunomodulatory
freeze
collected
Prior art date
Application number
PCT/CN2020/073062
Other languages
French (fr)
Chinese (zh)
Inventor
汪少芸
杨倩
蔡茜茜
陈旭
田永奇
Original Assignee
福州大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 福州大学 filed Critical 福州大学
Publication of WO2021082294A1 publication Critical patent/WO2021082294A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Definitions

  • the invention relates to a method for separating and purifying immunoregulatory peptides by using Radix Pseudostellariae, belonging to the field of biotechnology.
  • Immunity is a specific physiological response that occurs when the body comes into contact with "antigenic foreign bodies” or “different molecules”, and its main purpose is to maintain the body's homeostasis.
  • the immune system which is responsible for the body's immune function, is a network composed of cells, tissues and organs, used to eliminate potentially harmful substances, such as bacteria, viruses, fungi, and protozoa, and to prevent the growth of cancer cells. In the body's survival, the immune system acts as the first line of defense against pathogens and provides protection before the body's functions are damaged. However, the immune system is also affected by many factors, including stress, unhealthy lifestyles, pathogens and antigens, etc., which can destroy the body's immune system.
  • drugs used to regulate the human immune response came into being, such as cyclosporine, tacrolimus, glucocorticoids, plant alcohol, aristolochic acid, graphene and levamisole have been successfully applied to human immune response The adjustment.
  • drugs used to regulate the human immune response came into being, such as cyclosporine, tacrolimus, glucocorticoids, plant alcohol, aristolochic acid, graphene and levamisole have been successfully applied to human immune response The adjustment.
  • the toxic side effects and high cost of these drugs limit their use in patients, and most immunomodulatory drugs are not suitable for chronic or preventive use. Therefore, the discovery of new immunologically active peptides from food proteins has become an effective means of treatment and prevention.
  • Taizi ginseng is the root tuber of the caryophyllaceae plant Haier ginseng, also known as Tongshen, Four-leaf ginseng, Mi ginseng, etc. It has been recorded in many traditional Chinese medicine books since the Qing Dynasty "Materia Medica Congxin". It can invigorate qi and invigorate the spleen, promote body fluid and nourish the lungs. In TCM treatment, it is mostly used for spleen deficiency, weak appetite, weakness after illness, insufficient qi and yin, spontaneous sweating and thirst, dry cough in the lungs.
  • the main planting areas of Pseudostellaria are Fujian, Jiangsu, Shandong, Anhui, etc.
  • the present invention prepares high-efficiency immune polypeptides with specific amino acid sequences from the proteolysis of Radix Pseudostellariae.
  • the polypeptide can be applied to the food and health products industry.
  • the present invention provides a method for separating and purifying immunomodulatory peptides by using Radix Pseudostellariae.
  • the polypeptide obtained by the method has a specific amino acid sequence.
  • an immunomodulatory peptide of the present invention is Arg-Gly-Pro-Pro-Pro (RGPPP), and the preparation includes the following steps:
  • Step (1) The extraction of P. sylvestris protein is as follows: ground P. sylvestris into powder, and add the corresponding volume of 0.2-0.3 mol/L sodium hydroxide solution (NaOH) according to the mass concentration of P. sylvestris at 4.0-5.0%. Extract in a water bath at 50-60 °C for 1.0-3.0 h. After extraction, the supernatant was collected by centrifugation, and the pH value was adjusted to 2.5-3.5 with 1 mol/L hydrochloric acid (HCl). After standing for 1 to 3 h, the precipitate was collected by centrifugation and freeze-dried to obtain P. chinensis protein.
  • NaOH sodium hydroxide solution
  • step (2) the preparation of the proteolysate of Radix Pseudostellariae is as follows: the protein concentration of Radix Pseudostellariae is 1.0 ⁇ 2.0 w/v %, the pH is 1.5 ⁇ 2.5, the temperature is 30 ⁇ 40 °C, the enzymolysis time is 4.0 ⁇ 6.0 h, and 8.0 is added. ⁇ 10.0 w/w% pepsin for enzymatic hydrolysis. After the reaction is over, adjust the pH to 6.5 ⁇ 7.5, add 8.0 ⁇ 10.0 w/w% trypsin for enzymatic hydrolysis for 2.0 ⁇ 4.0 h. After the reaction, place it immediately Boil in a boiling water bath for 10-20 minutes to terminate the reaction. After the reaction, the solution is centrifuged to collect the supernatant and freeze-dried to obtain the proteolysis product of Radix ginseng.
  • step (3) The specific operation of the separation and purification of the proteolytic product of Pseudostellaria chinensis in step (3) is as follows: separate and purify the proteolytic solution of Pseudosciaena sylvestris in step (2).
  • Sephadex G25 uses deionized water as the eluent. The sample volume is 5 mL, the flow rate is 0.3 mL/min, and the detection wavelength is 214 nm.
  • the immunological activity of the eluent corresponding to each absorption peak is measured, and the components with the highest immunological activity are collected and separated by reversed-phase high performance liquid chromatography;
  • the separation of high performance liquid chromatography takes the acetonitrile solution with a concentration gradient of 0 ⁇ 55 v/v% containing 0.05% trifluoroacetic acid as the eluent for linear elution.
  • the column used is Gemini 5 ⁇ C18, and the sample volume is 100 ⁇ L, the flow rate is 1 mL/min, the detection wavelength is 214 nm, the immunological activity of the eluate corresponding to each absorption peak is measured, and the components with the highest immunological activity are collected and freeze-dried; the components are identified by Nano LC-MS/MS
  • the amino acid sequence Using Nano LC-MS/MS to identify the amino acid sequence of the components, the amino acid sequence of the immunomodulatory peptide according to claim 1 is: Arg-Gly-Pro-Pro-Pro.
  • step (3) The specific operation of the determination of immune activity in step (3) is as follows: the immune activity is evaluated by promoting the proliferation activity of mouse spleen lymphocytes in vitro.
  • the mouse spleen lymphocyte suspension was added to a 96-well plate, and phosphate buffer was used as a blank control.
  • the final concentrations of the samples were 10 ⁇ g/mL, 50 ⁇ g/mL, and 100 ⁇ g/mL, respectively.
  • the present invention is based on the disadvantages of the existing immunomodulatory drugs, such as side effects and high cost, and is dedicated to finding a natural immunomodulator. It starts from Pseudoginseng and focuses on the effects of pepsin and trypsin.
  • the two-step enzymatic hydrolysis process is controlled to prepare active peptides with specific peptide chain lengths, so that the immune activity can be efficiently realized.
  • the enzymolysis technology adopted by the invention is simple and efficient, can track the activity of enzymolysis products to achieve targeted enzymatic digestion, avoids cost waste, and the obtained polypeptide has immunological activity, which provides a theoretical basis for its application in the food and health product industries.
  • Figure 1 shows the G25 elution profile of the proteolysate of Radix Pseudostellariae (a) and the immunological activity of each component (b).
  • Figure 2 shows the elution profile of RP-HPLC (a) and the immunological activity of each component (b).
  • Figure 3 shows the total ion current of F18.
  • Figure 4 shows the peptide fingerprint of immunomodulatory peptides.
  • Figure 5 shows the proliferation-promoting activity of immunomodulatory peptides.
  • amino acid sequence of the immunomodulatory peptide of the present invention is Arg-Gly-Pro-Pro-Pro.
  • the preparation method is as follows:
  • Step 1 Use a Chinese medicine pulverizer to pulverize Radix sylvestris into powder, and pass through a 60-mesh sieve; weigh out 5.0 g of Radix sylvestris powder and add 105 mL 0.27 mol/L sodium hydroxide solution, leached at 52.1 °C for 1 h, centrifuged at 10,000 rpm for 20 min, then took the supernatant, adjusted pH to 3.0 with 1 mol/L hydrochloric acid, allowed to stand for 1 h, and centrifuged at 5,000 rpm for 20 min , Take the precipitate, freeze-dry it to become the ginseng protein.
  • the second step Weigh 10.0 g of Radix ginseng protein, add 100 mL of deionized water, adjust the pH to 2.0, add 0.8 g of pepsin, and place at 37 °C for enzymatic hydrolysis for 5.0 h, then adjust the pH to 7.0, add 0.8 g of pancreas Put the protease in 37 °C for 3.0 h, boil in a boiling water bath for 10 min to terminate the reaction, centrifuge at 10,000 rpm for 20 min, take the supernatant, freeze-dry it to obtain the proteolytic product of Radix Pseudostellariae.
  • Step 3 Weigh 100 mg of the proteolytic product of Pseudostellaria chinensis, add 5 mL of deionized water, stir until it is completely dissolved, centrifuge at 8,000 rpm for 20 min, take the supernatant, pass through a 0.22 ⁇ m filter membrane, and use Sephadex G25 Separation and purification: deionized water was used as the eluent, the flow rate was 0.3 mL/min, the detection wavelength was 214 nm, the immunological activity of the eluent corresponding to each absorption peak was measured, and the elution curve of each peak was determined ( Figure 1a) ) And immunological activity determination ( Figure 1b).
  • Step 4 Collect G3, which is the most immunologically active component, for reversed-phase high performance liquid chromatography separation: Weigh 200 mg of G3, add 5 mL of deionized water, fully dissolve it and pass through a 0.22 ⁇ m filter membrane, and load 100 ⁇ L . In the separation of reversed-phase high performance liquid chromatography, linear elution was performed with an acetonitrile solution containing a volume fraction of 0.05% trifluoroacetic acid with a concentration gradient of 0 ⁇ 55 v/v% as the eluent.
  • the column used was Gemini 5 ⁇ C18, and the flow rate was 1 mL/min, the detection wavelength is 214 nm, the immunological activity of the eluate corresponding to each absorption peak is measured, and the elution curve ( Figure 2a) and immunological activity ( Figure 2b) of each peak obtained are measured.
  • Step 5 Collect F18, the component with the highest immunological activity, and use Nano LC-MS/MS to identify the amino acid sequence of the component after freeze-drying.
  • Nano LC-MS/MS to identify the amino acid sequence of the components, the total ion current diagram is shown in Figure 3, and then using MS/MS to identify the 77.35 min ion peak, the full amino acid sequence is obtained as (shown in Figure 4): Arg-Gly-Pro-Pro-Pro (molecular weight is 522 Da) is the immunomodulatory peptide of the present invention.
  • the sixth step the immune activity is evaluated by promoting the in vitro proliferation activity of mouse spleen lymphocytes.
  • the mouse spleen lymphocyte suspension was added to a 96-well plate, and phosphate buffer was used as a blank control.
  • the final concentrations of the samples were 10 ⁇ g/mL, 50 ⁇ g/mL, and 100 ⁇ g/mL, respectively.
  • the immunomodulatory peptide of the present invention reaches a maximum spleen cell stimulation index of 1.25 when the stimulation time is 48 hours and the concentration is 100 ⁇ g/mL ( Figure 5).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Provided is a method for isolating and purifying an immunomodulatory peptide by using Pseudostellaria heterophylla. The method uses Pseudostellaria heterophylla as a raw material to obtain a specific immunity polypeptide after using protein extraction, the two-step enzymolysis of pepsin and trypsin, isolation and purification, and freeze-drying. The polypeptide has a molecular weight of 522 Da, and the full amino acid sequence thereof is: Arg-Gly-Pro-Pro-Pro. The present invention eliminates the defects present in immunomodulatory drugs, and eliminates public worries about artificial immunomodulators; in addition, the present invention lays the theoretical foundation for the development of immunity peptides based on food sources as well as for the exploration of the wide applications thereof in food and medicine.

Description

一种免疫调节肽的制备及方法Preparation and method of immunomodulatory peptide 技术领域Technical field
本发明涉及一种利用太子参分离纯化免疫调节肽的方法,属于生物技术领域。The invention relates to a method for separating and purifying immunoregulatory peptides by using Radix Pseudostellariae, belonging to the field of biotechnology.
背景技术Background technique
免疫是机体接触“抗原性异物”或“异己分子”所发生的一种特异性生理反应,其主要目的是维持机体的内稳态。而负责执行机体免疫功能的免疫系统是个由细胞、组织和器官组成的网络,用来消除潜在的有害物质,如细菌、病毒、真菌、原生动物,并阻止癌细胞的生长。在机体的生存中,免疫系统作为抵御病原体的第一道防线,在身体功能受损伤前提供保护。但是,免疫系统也受到许多因素的影响,包括压力、不健康的生活方式、病原体和抗原等都会破坏机体的免疫系统。于是,用于调节人体免疫反应的药物应运而生,如环孢霉素、他克莫司、糖皮质激素、植物醇、马兜铃酸、石墨烯和左旋咪唑等已成功应用于人类免疫反应的调节。然而,这些药物的毒副作用和高成本限制了它们在病人中的使用,而且,大多数免疫调节药物不适合慢性或预防性使用。因此,从食物蛋白中发现新型免疫活性肽成为一种有效的治疗和预防手段。Immunity is a specific physiological response that occurs when the body comes into contact with "antigenic foreign bodies" or "different molecules", and its main purpose is to maintain the body's homeostasis. The immune system, which is responsible for the body's immune function, is a network composed of cells, tissues and organs, used to eliminate potentially harmful substances, such as bacteria, viruses, fungi, and protozoa, and to prevent the growth of cancer cells. In the body's survival, the immune system acts as the first line of defense against pathogens and provides protection before the body's functions are damaged. However, the immune system is also affected by many factors, including stress, unhealthy lifestyles, pathogens and antigens, etc., which can destroy the body's immune system. As a result, drugs used to regulate the human immune response came into being, such as cyclosporine, tacrolimus, glucocorticoids, plant alcohol, aristolochic acid, graphene and levamisole have been successfully applied to human immune response The adjustment. However, the toxic side effects and high cost of these drugs limit their use in patients, and most immunomodulatory drugs are not suitable for chronic or preventive use. Therefore, the discovery of new immunologically active peptides from food proteins has become an effective means of treatment and prevention.
技术问题technical problem
太子参是石竹科植物孩儿参的块根,又名童参、四叶参、米参等,自清代《本草从新》开始就被记录于多本中医著作中,其属于补虚补气药,可益气健脾,生津润肺,中医治疗中多用于脾虚体弱,食欲不振,病后虚弱,气阴不足,自汗口渴,肺燥干咳。太子参的主要种植地区有福建、江苏、山东、安徽等,其中福建柘荣自清末起就有种植,且闻名国内外,有“太子参之乡”的美誉。迄今为止对于太子参的化学成分与药用功效的研究颇多,但是对于太子参蛋白酶解制备多肽还未有相关报道。Taizi ginseng is the root tuber of the caryophyllaceae plant Haier ginseng, also known as Tongshen, Four-leaf ginseng, Mi ginseng, etc. It has been recorded in many traditional Chinese medicine books since the Qing Dynasty "Materia Medica Congxin". It can invigorate qi and invigorate the spleen, promote body fluid and nourish the lungs. In TCM treatment, it is mostly used for spleen deficiency, weak appetite, weakness after illness, insufficient qi and yin, spontaneous sweating and thirst, dry cough in the lungs. The main planting areas of Pseudostellaria are Fujian, Jiangsu, Shandong, Anhui, etc. Among them, Zherong, Fujian has been planted since the end of Qing Dynasty, and is well-known at home and abroad, and has the reputation of "Hometown of Pseudostellaria". So far, there have been many studies on the chemical composition and medicinal effects of P. sylvestris, but there are no relevant reports on the preparation of polypeptides by proteolysis of P. sylvestris.
因此,本发明从太子参蛋白酶解物中制备具有特定氨基酸序列的高效免疫多肽。该多肽可以应用于食品和保健品行业。Therefore, the present invention prepares high-efficiency immune polypeptides with specific amino acid sequences from the proteolysis of Radix Pseudostellariae. The polypeptide can be applied to the food and health products industry.
技术解决方案Technical solutions
为了解决上述问题,本发明提供了一种利用太子参分离纯化免疫调节肽的方法,通过该方法得到的多肽具有特定的氨基酸序列。In order to solve the above-mentioned problems, the present invention provides a method for separating and purifying immunomodulatory peptides by using Radix Pseudostellariae. The polypeptide obtained by the method has a specific amino acid sequence.
为实现上述目的,采用以下技术方案:In order to achieve the above objectives, the following technical solutions are adopted:
本发明的一种免疫调节肽,氨基酸序列为Arg-Gly-Pro-Pro-Pro(RGPPP),制备包括如下步骤:An immunomodulatory peptide of the present invention, the amino acid sequence is Arg-Gly-Pro-Pro-Pro (RGPPP), and the preparation includes the following steps:
(1)太子参蛋白质的提取:将太子参研磨成粉末,采用碱提酸沉法提取太子参蛋白质;(1) Extraction of P. sylvestris protein: Grind P. sylvestris into powder, and extract P. sylvestris protein with alkali extraction and acid precipitation;
(2)太子参蛋白酶解物的制备:利用胃蛋白酶和胰蛋白酶对太子参蛋白进行双步酶解,得到太子参蛋白酶解物;(2) Preparation of Pseudostellaria chinensis proteolysate: use pepsin and trypsin to carry out two-step enzymatic hydrolysis of Pseudosciaena serrata protein to obtain the hydrolysate of Pseudostellaria chinensis;
(3)太子参蛋白酶解物的分离纯化:葡聚糖凝胶G25层析和RP-HPLC反相高效液相色谱对太子参蛋白酶解物分离纯化,收集免疫活性最高的组分冷冻干燥,并利用Nano LC-MS/MS鉴定组分的氨基酸序列。(3) Separation and purification of the proteolysate of Pseudosciaena sylvestris: Sephadex G25 chromatography and RP-HPLC reversed-phase high performance liquid chromatography to separate and purify the proteolysis of Pseudosciaena sylvestris, collect the most immunologically active components and freeze-dry them, and The amino acid sequence of the components was identified by Nano LC-MS/MS.
步骤(1)中太子参蛋白质的提取如下:将太子参研磨成粉末,并按照太子参粉末质量浓度为4.0~5.0 %加入相应体积的0.2~0.3 mol/L的氢氧化钠溶液(NaOH),在50~60 °C水浴中浸提1.0~3.0 h。浸提后离心收集上清液,采用1 mol/L的盐酸(HCl)调节pH值至2.5~3.5,静置1~3 h后,离心收集沉淀冷冻干燥,得到太子参蛋白。Step (1) The extraction of P. sylvestris protein is as follows: ground P. sylvestris into powder, and add the corresponding volume of 0.2-0.3 mol/L sodium hydroxide solution (NaOH) according to the mass concentration of P. sylvestris at 4.0-5.0%. Extract in a water bath at 50-60 °C for 1.0-3.0 h. After extraction, the supernatant was collected by centrifugation, and the pH value was adjusted to 2.5-3.5 with 1 mol/L hydrochloric acid (HCl). After standing for 1 to 3 h, the precipitate was collected by centrifugation and freeze-dried to obtain P. chinensis protein.
步骤(2)中太子参蛋白酶解物的制备如下:太子参蛋白浓度为1.0~2.0 w/v %、pH为1.5~2.5、温度30~40 ℃、酶解时间为4.0~6.0 h、加入8.0~10.0 w/w %的胃蛋白酶进行酶解,反应结束后,调节pH至6.5~7.5,加入8.0~10.0 w/w %的胰蛋白酶,酶解2.0~4.0 h,反应结束后,立即放置于沸水浴中煮沸10~20 min,终止反应,反应后的溶液离心收集上清液冷冻干燥,得到太子参蛋白酶解产物。In step (2), the preparation of the proteolysate of Radix Pseudostellariae is as follows: the protein concentration of Radix Pseudostellariae is 1.0~2.0 w/v %, the pH is 1.5~2.5, the temperature is 30~40 ℃, the enzymolysis time is 4.0~6.0 h, and 8.0 is added. ~10.0 w/w% pepsin for enzymatic hydrolysis. After the reaction is over, adjust the pH to 6.5~7.5, add 8.0~10.0 w/w% trypsin for enzymatic hydrolysis for 2.0~4.0 h. After the reaction, place it immediately Boil in a boiling water bath for 10-20 minutes to terminate the reaction. After the reaction, the solution is centrifuged to collect the supernatant and freeze-dried to obtain the proteolysis product of Radix ginseng.
步骤(3)中太子参蛋白酶解物的分离纯化具体操作如下:将步骤(2)中所述太子参蛋白酶解液进行分离纯化,葡聚糖凝胶G25以去离子水作为洗脱液,上样量为5mL,流速为0.3 mL/min,检测波长为214 nm,测定各吸收峰对应的洗脱液的免疫活性,收集得到免疫活性最高的组分进行反相高效液相色谱分离;反相高效液相色谱的分离以含体积分数0.05 %三氟乙酸的浓度梯度为0~55 v/v%的乙腈溶液作为洗脱液进行线性洗脱,所用色谱柱为Gemini 5μ C18,上样量为100 μL,流速为1 mL/min,检测波长为214 nm,测定各吸收峰对应的洗脱液的免疫活性,收集得到免疫活性最高的组分冷冻干燥;利用Nano LC-MS/MS鉴定组分的氨基酸序列。利用Nano LC-MS/MS鉴定组分的氨基酸序列,得到如权利要求1所述的免疫调节肽的氨基酸序列为:Arg-Gly-Pro-Pro-Pro。The specific operation of the separation and purification of the proteolytic product of Pseudostellaria chinensis in step (3) is as follows: separate and purify the proteolytic solution of Pseudosciaena sylvestris in step (2). Sephadex G25 uses deionized water as the eluent. The sample volume is 5 mL, the flow rate is 0.3 mL/min, and the detection wavelength is 214 nm. The immunological activity of the eluent corresponding to each absorption peak is measured, and the components with the highest immunological activity are collected and separated by reversed-phase high performance liquid chromatography; The separation of high performance liquid chromatography takes the acetonitrile solution with a concentration gradient of 0~55 v/v% containing 0.05% trifluoroacetic acid as the eluent for linear elution. The column used is Gemini 5μ C18, and the sample volume is 100 μL, the flow rate is 1 mL/min, the detection wavelength is 214 nm, the immunological activity of the eluate corresponding to each absorption peak is measured, and the components with the highest immunological activity are collected and freeze-dried; the components are identified by Nano LC-MS/MS The amino acid sequence. Using Nano LC-MS/MS to identify the amino acid sequence of the components, the amino acid sequence of the immunomodulatory peptide according to claim 1 is: Arg-Gly-Pro-Pro-Pro.
步骤(3)中免疫活性的测定具体操作如下:免疫活性以促进小鼠脾淋巴细胞体外增殖活性进行评价。取小鼠脾淋巴细胞悬浮液加入96孔板,以磷酸盐缓冲液为空白对照,样品终浓度分别为10 μg/mL、50 μg/mL、100 μg/mL。加样品后置于37 °C 5% CO 2培养箱中培养不同时间后,每孔加入20 μL 3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(5 mg/mL),继续培养4 h,离心弃上清后加入200 μL二甲亚砜,低速震荡10 min,检测570 nm处吸光值。 The specific operation of the determination of immune activity in step (3) is as follows: the immune activity is evaluated by promoting the proliferation activity of mouse spleen lymphocytes in vitro. The mouse spleen lymphocyte suspension was added to a 96-well plate, and phosphate buffer was used as a blank control. The final concentrations of the samples were 10 μg/mL, 50 μg/mL, and 100 μg/mL, respectively. After adding the sample, place it in a 37 °C 5% CO 2 incubator for different periods of time, add 20 μL of 3-(4,5-dimethylthiazole-2)-2,5-diphenyltetrazolium to each well Bromide salt (5 mg/mL), continue to incubate for 4 h, centrifuge to discard the supernatant, add 200 μL of dimethyl sulfoxide, shake at low speed for 10 min, and detect the absorbance at 570 nm.
Figure 94204dest_path_image001
Figure 94204dest_path_image001
.
有益效果Beneficial effect
本发明的有益效果在于:本发明立足于现有免疫调节药物的毒副作用及高成本等缺点,致力于寻找一种天然的免疫调节剂,以太子参为出发点,着眼于胃蛋白酶和胰蛋白酶的双步酶解的过程控制,制备具有特定肽链长度的活性多肽,使得免疫活性得以高效的实现。本发明采用的酶解技术简单高效,能对酶解产物进行活性跟踪从而达到定向酶切,避免了成本浪费,得到的多肽具备免疫活性,为其应用于食品和保健品行业提供理论基础。The beneficial effects of the present invention are: the present invention is based on the disadvantages of the existing immunomodulatory drugs, such as side effects and high cost, and is dedicated to finding a natural immunomodulator. It starts from Pseudoginseng and focuses on the effects of pepsin and trypsin. The two-step enzymatic hydrolysis process is controlled to prepare active peptides with specific peptide chain lengths, so that the immune activity can be efficiently realized. The enzymolysis technology adopted by the invention is simple and efficient, can track the activity of enzymolysis products to achieve targeted enzymatic digestion, avoids cost waste, and the obtained polypeptide has immunological activity, which provides a theoretical basis for its application in the food and health product industries.
附图说明Description of the drawings
图1为太子参蛋白酶解物的G25洗脱图(a)及各组分的免疫活性(b)。Figure 1 shows the G25 elution profile of the proteolysate of Radix Pseudostellariae (a) and the immunological activity of each component (b).
图2为RP-HPLC洗脱图(a)及各组分的免疫活性(b)。Figure 2 shows the elution profile of RP-HPLC (a) and the immunological activity of each component (b).
图3为F18总离子流图。Figure 3 shows the total ion current of F18.
图4为免疫调节肽的肽指纹图谱。Figure 4 shows the peptide fingerprint of immunomodulatory peptides.
图5为免疫调节肽的促增殖活性。Figure 5 shows the proliferation-promoting activity of immunomodulatory peptides.
本发明的实施方式Embodiments of the present invention
实施例Example 11
本发明的免疫调节肽的氨基酸序列为Arg-Gly-Pro-Pro-Pro。The amino acid sequence of the immunomodulatory peptide of the present invention is Arg-Gly-Pro-Pro-Pro.
制备方法如下:The preparation method is as follows:
第一步:利用中药粉碎机将太子参粉碎成粉末,过60目筛;称取5.0 g太子参粉末,加入105 mL 0.27 mol/L的氢氧化钠溶液,52.1 ℃下浸提1 h,10,000 rpm离心20 min后取上清液,采用1 mol/L的盐酸调节pH至3.0,静置1 h,5,000 rpm离心20 min,取沉淀,冷冻干燥即为太子参蛋白。Step 1: Use a Chinese medicine pulverizer to pulverize Radix sylvestris into powder, and pass through a 60-mesh sieve; weigh out 5.0 g of Radix sylvestris powder and add 105 mL 0.27 mol/L sodium hydroxide solution, leached at 52.1 ℃ for 1 h, centrifuged at 10,000 rpm for 20 min, then took the supernatant, adjusted pH to 3.0 with 1 mol/L hydrochloric acid, allowed to stand for 1 h, and centrifuged at 5,000 rpm for 20 min , Take the precipitate, freeze-dry it to become the ginseng protein.
第二步:称取太子参蛋白10.0 g,加入100 mL去离子水,调节pH至2.0,加入0.8 g胃蛋白酶,置于37 ℃中酶解5.0 h后,调节pH至7.0,加入0.8 g胰蛋白酶,置于37 ℃中酶解3.0 h,置于沸水浴中煮沸10 min终止反应,10,000 rpm离心20 min,取上清,冷冻干燥即为太子参蛋白酶解物。The second step: Weigh 10.0 g of Radix ginseng protein, add 100 mL of deionized water, adjust the pH to 2.0, add 0.8 g of pepsin, and place at 37 ℃ for enzymatic hydrolysis for 5.0 h, then adjust the pH to 7.0, add 0.8 g of pancreas Put the protease in 37 ℃ for 3.0 h, boil in a boiling water bath for 10 min to terminate the reaction, centrifuge at 10,000 rpm for 20 min, take the supernatant, freeze-dry it to obtain the proteolytic product of Radix Pseudostellariae.
第三步:称取太子参蛋白酶解物100 mg,加入5 mL去离子水,搅拌直至完全溶解,8,000 rpm离心20 min,取上清,过0.22 μm滤膜,利用葡聚糖凝胶G25进行分离纯化:以去离子水作为洗脱液,流速为0.3 mL/min,检测波长为214 nm,测定各吸收峰对应的洗脱液的免疫活性,测定得到的各峰的洗脱曲线(图1a)和免疫活性测定(图1b)。Step 3: Weigh 100 mg of the proteolytic product of Pseudostellaria chinensis, add 5 mL of deionized water, stir until it is completely dissolved, centrifuge at 8,000 rpm for 20 min, take the supernatant, pass through a 0.22 μm filter membrane, and use Sephadex G25 Separation and purification: deionized water was used as the eluent, the flow rate was 0.3 mL/min, the detection wavelength was 214 nm, the immunological activity of the eluent corresponding to each absorption peak was measured, and the elution curve of each peak was determined (Figure 1a) ) And immunological activity determination (Figure 1b).
第四步:收集得到免疫活性最高的组分G3进行反相高效液相色谱分离:称取G3 200 mg,加入5 mL去离子水,充分溶解后过0.22 μm滤膜,上样量为100 μL。反相高效液相色谱的分离以含体积分数0.05 %三氟乙酸的浓度梯度为0~55 v/v%的乙腈溶液作为洗脱液进行线性洗脱,所用色谱柱为Gemini 5μ C18,流速为1 mL/min,检测波长为214 nm,测定各吸收峰对应的洗脱液的免疫活性,测定得到的各峰的洗脱曲线(图2a)和免疫活性(图2b)。Step 4: Collect G3, which is the most immunologically active component, for reversed-phase high performance liquid chromatography separation: Weigh 200 mg of G3, add 5 mL of deionized water, fully dissolve it and pass through a 0.22 μm filter membrane, and load 100 μL . In the separation of reversed-phase high performance liquid chromatography, linear elution was performed with an acetonitrile solution containing a volume fraction of 0.05% trifluoroacetic acid with a concentration gradient of 0~55 v/v% as the eluent. The column used was Gemini 5μ C18, and the flow rate was 1 mL/min, the detection wavelength is 214 nm, the immunological activity of the eluate corresponding to each absorption peak is measured, and the elution curve (Figure 2a) and immunological activity (Figure 2b) of each peak obtained are measured.
第五步:收集得到免疫活性最高的组分F18,冷冻干燥后利用Nano LC-MS/MS鉴定组分的氨基酸序列。利用Nano LC-MS/MS鉴定组分的氨基酸序列,其总离子流图如图3所示,再利用MS/MS鉴定77.35 min离子峰,得到其氨基酸全序列为(如图4所示):Arg-Gly-Pro-Pro-Pro(分子量为522 Da),即为本发明的免疫调节肽。Step 5: Collect F18, the component with the highest immunological activity, and use Nano LC-MS/MS to identify the amino acid sequence of the component after freeze-drying. Using Nano LC-MS/MS to identify the amino acid sequence of the components, the total ion current diagram is shown in Figure 3, and then using MS/MS to identify the 77.35 min ion peak, the full amino acid sequence is obtained as (shown in Figure 4): Arg-Gly-Pro-Pro-Pro (molecular weight is 522 Da) is the immunomodulatory peptide of the present invention.
第六步:免疫活性以促进小鼠脾淋巴细胞体外增殖活性进行评价。取小鼠脾淋巴细胞悬浮液加入96孔板,以磷酸盐缓冲液为空白对照,样品终浓度分别为10 μg/mL、50 μg/mL、100 μg/mL。加样品后置于37 °C 5% CO 2培养箱中培养不同时间后,每孔加入20 μL 3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(5 mg/mL),继续培养4 h,离心弃上清后加入200 μL二甲亚砜,低速震荡10 min,检测570 nm处吸光值。本发明的免疫调节肽在刺激时间为48h,浓度为100 μg/mL时达到最大脾细胞刺激指数1.25(图5)。 The sixth step: the immune activity is evaluated by promoting the in vitro proliferation activity of mouse spleen lymphocytes. The mouse spleen lymphocyte suspension was added to a 96-well plate, and phosphate buffer was used as a blank control. The final concentrations of the samples were 10 μg/mL, 50 μg/mL, and 100 μg/mL, respectively. After adding the sample, place it in a 37 °C 5% CO 2 incubator for different periods of time, add 20 μL of 3-(4,5-dimethylthiazole-2)-2,5-diphenyltetrazolium to each well Bromide salt (5 mg/mL), continue to incubate for 4 h, centrifuge to discard the supernatant, add 200 μL of dimethyl sulfoxide, shake at low speed for 10 min, and detect the absorbance at 570 nm. The immunomodulatory peptide of the present invention reaches a maximum spleen cell stimulation index of 1.25 when the stimulation time is 48 hours and the concentration is 100 μg/mL (Figure 5).
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。The foregoing descriptions are only preferred embodiments of the present invention, and all equivalent changes and modifications made in accordance with the scope of the patent application of the present invention should fall within the scope of the present invention.

Claims (5)

  1. 一种免疫调节肽,其特征在于:所述免疫多肽的氨基酸序列为Arg-Gly-Pro-Pro-Pro。An immunomodulatory peptide, characterized in that the amino acid sequence of the immunological polypeptide is Arg-Gly-Pro-Pro-Pro.
  2. 一种如权利要求1所述的免疫调节肽制备方法,其特征在于:以太子参为原料,对其进行蛋白质提取,并对蛋白质进行酶解,分离纯化、冷冻干燥得到免疫多肽。A method for preparing immunomodulatory peptides according to claim 1, characterized in that: using Pseudostellaria chinensis as a raw material, protein is extracted from it, and the protein is subjected to enzymatic hydrolysis, separation, purification, and freeze-drying to obtain immune peptides.
  3. 根据权利要求2所述的免疫调节肽的制备方法,其特征在于:所述蛋白质提取的具体步骤为:将太子参研磨成粉末,并按照太子参粉末质量浓度为4.0~5.0 %加入0.2~0.3 mol/L的氢氧化钠溶液,然后在50~60 °C浸提1.0~3.0 h;浸提后离心收集上清液,采用1 mol/L的盐酸调节上清液pH值至2.5~3.5,沉降1~3 h后,离心后冷冻干燥得到太子参蛋白。The method for preparing immunomodulatory peptides according to claim 2, characterized in that: the specific steps of protein extraction are: ground ginseng into powder, and add 0.2 to 0.3 according to the mass concentration of ginseng powder of 4.0-5.0% mol/L sodium hydroxide solution, and then leached at 50-60 °C for 1.0-3.0 h; after leaching, the supernatant was collected by centrifugation, and the pH of the supernatant was adjusted to 2.5-3.5 with 1 mol/L hydrochloric acid. After 1~3 hours of sedimentation, centrifugation and freeze-drying to obtain the ginseng protein.
  4. 根据权利要求2所述的免疫调节肽的制备方法,其特征在于:所述酶解的具体步骤为:太子参蛋白浓度为1.0~2.0w/v%、pH为1.5~2.5、温度30~40 ℃、酶解时间为4.0~6.0 h、添加8.0~10.0 w/w %的胃蛋白酶进行酶解,反应结束后,调节pH至6.5~7.5,添加8.0~10.0 w/w %的胰蛋白酶酶解2.0~4.0 h,反应结束后,立即放在沸水浴中煮沸10~20 min,终止反应,离心收集上清,得到免疫调节肽酶解产物。The method for preparing immunomodulatory peptides according to claim 2, wherein the specific steps of the enzymatic hydrolysis are: the protein concentration of Pseudostellaria heterophylla is 1.0~2.0w/v%, the pH is 1.5~2.5, and the temperature is 30~40. ℃, enzymolysis time is 4.0~6.0 h, add 8.0~10.0 w/w% pepsin for enzymolysis, after the reaction is over, adjust the pH to 6.5~7.5, add 8.0~10.0 w/w% trypsin for enzymolysis After the reaction is completed for 2.0 to 4.0 h, immediately place it in a boiling water bath and boil for 10 to 20 minutes, terminate the reaction, and collect the supernatant by centrifugation to obtain the immunomodulatory peptide enzymatic hydrolysis product.
  5. 根据权利要求2所述的免疫调节肽的制备方法,其特征在于:所述分离纯化的具体步骤为:利用葡聚糖凝胶G25层析和RP-HPLC反相高效液相色谱分离酶解产物,并监控分离组分的免疫活性,收集具有最佳免疫活性的组分;葡聚糖凝胶G25的分离以去离子水作为洗脱液,上样量为5mL,流速为0.3 mL/min,检测波长为214 nm,测定各吸收峰对应的洗脱液的免疫活性,收集得到免疫活性最高的组分进行反相高效液相色谱分离;反相高效液相色谱的分离以含体积分数0.05 %三氟乙酸的浓度梯度为0~55 v/v%的乙腈溶液作为洗脱液进行线性洗脱,所用色谱柱为Gemini 5μ C18,上样量为100 μL,流速为1 mL/min,检测波长为214 nm,测定各吸收峰对应的洗脱液的免疫活性,收集得到免疫活性最高的组分;冷冻干燥后利用Nano LC-MS/MS鉴定组分的氨基酸序列。The method for preparing immunomodulatory peptides according to claim 2, characterized in that: the specific steps of separation and purification are: Sephadex G25 chromatography and RP-HPLC reversed-phase high performance liquid chromatography are used to separate the enzymatic hydrolysis products , And monitor the immunological activity of the separated components, and collect the components with the best immunological activity; the separation of Sephadex G25 uses deionized water as the eluent, the sample volume is 5 mL, and the flow rate is 0.3 mL/min. The detection wavelength is 214 nm, and the immunological activity of the eluent corresponding to each absorption peak is measured, and the components with the highest immunological activity are collected for reversed-phase high performance liquid chromatography; the reversed-phase high performance liquid chromatography is separated with a volume fraction of 0.05% The concentration gradient of trifluoroacetic acid is 0~55 v/v% acetonitrile solution was used as the eluent for linear elution. The column used was Gemini 5μ C18, the sample volume was 100 μL, the flow rate was 1 mL/min, the detection wavelength was 214 nm, and the corresponding absorption peaks were measured. The immune activity of the eluate is collected and the component with the highest immune activity is collected; after freeze-drying, the amino acid sequence of the component is identified by Nano LC-MS/MS.
PCT/CN2020/073062 2019-10-31 2020-01-19 Preparation of and method for immunomodulatory peptide WO2021082294A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911050848.4A CN110655556B (en) 2019-10-31 2019-10-31 Preparation and method of immunoregulatory peptide
CN201911050848.4 2019-10-31

Publications (1)

Publication Number Publication Date
WO2021082294A1 true WO2021082294A1 (en) 2021-05-06

Family

ID=69042454

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/073062 WO2021082294A1 (en) 2019-10-31 2020-01-19 Preparation of and method for immunomodulatory peptide

Country Status (2)

Country Link
CN (1) CN110655556B (en)
WO (1) WO2021082294A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110655556B (en) * 2019-10-31 2021-05-18 福州大学 Preparation and method of immunoregulatory peptide
CN111825745B (en) * 2020-07-29 2022-03-04 中国科学院华南植物园 Immunoregulatory active heptapeptide and preparation method and application thereof
CN111978374B (en) * 2020-07-29 2022-03-04 中国科学院华南植物园 Immunoregulation active hexapeptide and preparation method and application thereof
CN114195860B (en) * 2021-12-16 2023-07-25 吉林国瑞医药有限公司 Anti-angiogenesis and anti-tumor active peptide derived from codonopsis pilosula as well as preparation method and application thereof
CN114213516B (en) * 2021-12-16 2023-07-25 吉林国瑞医药有限公司 Active peptide derived from radix codonopsis pilosulae for promoting lactation and resisting breast tumor, and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110655556A (en) * 2019-10-31 2020-01-07 福州大学 Preparation and method of immunoregulatory peptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103923191A (en) * 2014-04-28 2014-07-16 中国科学院昆明植物研究所 Preparation method of standard radix pseudostellariae cyclopeptide B
CN104610430B (en) * 2015-02-26 2018-02-27 江苏安惠生物科技有限公司 Antioxidation polypeptide prepared using ganoderma lucidum albumen and preparation method thereof
CN108840928B (en) * 2018-06-26 2020-09-01 福州大学 Radix pseudostellariae trypsin inhibitor and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110655556A (en) * 2019-10-31 2020-01-07 福州大学 Preparation and method of immunoregulatory peptide

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
YANG QIAN, CAI XIXI, HUANG MUCHEN, JIA LEE, WANG SHAOYUN: "Immunomodulatory effects of Pseudostellaria heterophylla peptide on spleen lymphocytes via a Ca 2+ /CaN/NFATc1/IFN-γ pathway", FOOD & FUNCTION, R S C PUBLICATIONS, GB, vol. 10, no. 6, 19 June 2019 (2019-06-19), GB, pages 3466 - 3476, XP055809259, ISSN: 2042-6496, DOI: 10.1039/C9FO00577C *
YANG QIAN; CAI XIXI; HUANG MUCHEN; WANG SHAOYUN: "A specific peptide with immunomodulatory activity from Pseudostellaria heterophylla and the action mechanism", JOURNAL OF FUNCTIONAL FOODS, ELSEVIER BV, NL, vol. 68, 15 March 2020 (2020-03-15), NL, XP086145334, ISSN: 1756-4646, DOI: 10.1016/j.jff.2020.103887 *
YANG QIAN; HUANG MUCHEN; CAI XIXI; JIA LEE; WANG SHAOYUN: "Investigation on activation in RAW264.7 macrophage cells and protection in cyclophosphamide-treated mice of Pseudostellaria heterophylla protein hydrolysate", FOOD AND CHEMICAL TOXICOLOGY, PERGAMON, GB, vol. 134, 10 September 2019 (2019-09-10), GB, XP085885961, ISSN: 0278-6915, DOI: 10.1016/j.fct.2019.110816 *

Also Published As

Publication number Publication date
CN110655556B (en) 2021-05-18
CN110655556A (en) 2020-01-07

Similar Documents

Publication Publication Date Title
WO2021082294A1 (en) Preparation of and method for immunomodulatory peptide
CN110590907B (en) Preparation, separation and purification method of immunoregulatory peptide
Hu et al. Antioxidant activity of Inonotus obliquus polysaccharide and its amelioration for chronic pancreatitis in mice
CN109400678A (en) A kind of anti-oxidant and DPP-IV inhibitory activity peptide in stichopus japonicus source
KR100700912B1 (en) Human Cell Binding Inhibitory Activity of Acne Bacillus and Atopic Staphylococcus aureus Containing Acidic Polysaccharides Isolated from Green Tea Leaves
CN105254708B (en) A kind of anti-oxidant tripeptides of carrot seed and the preparation method and application thereof
CN108715600B (en) Oligopeptide for promoting proliferation and migration of intestinal mucosa epithelial cells and preparation method and application thereof
CN105063152A (en) Polypeptide raw material prepared by enzymolysis of walnuts and application thereof
Liu et al. Oligopeptide derived from solid-state fermented cottonseed meal significantly affect the immunomodulatory in BALB/c mice treated with cyclophosphamide
CN103539831B (en) Ansu apricot alpha-glucosaccharase enzyme inhibition peptide and its production and use
CN103204904B (en) Dasyatis akajei chondroprotein polypeptide capable of resisting prostate cancer, and preparation method and application thereof
CN109628535A (en) A kind of purple perilla antineoplastic polypeptide and its preparation method and application
CN103539833B (en) High reactivity alpha-glucosaccharase enzyme inhibition peptide and its production and use
CN107698659B (en) Amygdalus sinica protein source alpha-glucosidase inhibitory peptide subjected to enzymolysis by protease M and preparation method thereof
WO2020108629A1 (en) Polypeptide rdp1 and purification method and use therefor
WO2009127130A1 (en) Achyranthes bidentata polypeptide and production methods and uses thereof
CN110734947A (en) preparation method of oat blood pressure lowering polypeptide
CN104774255B (en) The biologically active peptide in jellyfish source and preparation method thereof
CN115960165A (en) Selenium-rich ACE inhibitory peptide derived from moringa oleifera leaves and application thereof
CN107746426B (en) Amygdalus communis protein source alpha-glucosidase inhibitory peptide subjected to enzymolysis by protease Prote AX and preparation method thereof
CN105131083A (en) Flat almond peptides capable of inhibiting activity of angiotensin converting enzyme (ACE) and preparation method thereof
CN114989250A (en) Angiotensin converting enzyme inhibitory polypeptide derived from seawater pearl and application thereof
CN115124591A (en) Spirulina platensis phycocyanin angiotensin converting enzyme inhibitory peptide and preparation method and application thereof
CN114032267A (en) Preparation method and application of active peptide
CN104945533B (en) A kind of preparation method of active corn stigma holosaccharide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20883582

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20883582

Country of ref document: EP

Kind code of ref document: A1